← Open Payments lookup

BELKIS LORENZO GIMENO: Open Payments

NPI 1770073421 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$314 in 17 payments from 6 companies in 2025. Trend: 2023 $227 · 2024 $665 · 2025 $314

Food & beverage: $314
CompanyPaymentsAmount
Amgen Inc.10$182
Boehringer Ingelheim Pharmaceuticals, Inc.3$49
Lilly USA, LLC1$24
Cipher Pharmaceuticals US LLC1$22
Novo Nordisk Inc1$21
AstraZeneca Pharmaceuticals LP1$16

Products named: REPATHA, OTEZLA, JARDIANCE, MOUNJARO, Natroba, Ozempic, AIRSUPRA.

Industry payments across TX — which companies pay providers there.